<DOC>
	<DOC>NCT00191841</DOC>
	<brief_summary>To evaluate the clinical response rate of neoadjuvant chemotherapy with gemcitabine and cisplatin in patients with operable NSCLC</brief_summary>
	<brief_title>Gemcitabine in Combination With Cisplatin as Neoadjuvant NSCLC Chemotherapy</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>histologic or cytologic diagnosis of operable nonsmall cell lung cancer (IBIIIA) no prior chemotherapy WHO criteria for disease status assessment Concurrent administration of any other tumor therapy pregnant or breast feeding serious concomitant disorders</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2006</verification_date>
</DOC>